News

Takeda has submitted the NDA for the compound on the basis of the results from four Phase 3 clinical trials conducted in Japan. In those trials, Takeda has

As per the agreement, Seattle Genetics is eligible to receive a sum of $8m as an upfront payment from Abbott. Further, Seattle Genetics is also entitled to get

The AmplideX FMR1 PCR Kit will help in the diagnosis of fragile X syndrome and associated disorders, and can accurately resolve sample zygosity and detect the full range

Hi-Tech Pharmacal claims Ranitidine syrup is the generic version of GlaxoSmithKline’s Zantac syrup. Ranitidine syrup is indicated for the treatment of duodenal ulcers. Hi-Tech Pharmacal is a specialty

The patent portfolio includes a number of novel chemical entities from Nectid’s Pain Drug Discovery program and two key drug delivery platforms. Nectid president and CEO Veena Rao

The study calls for recruiting up to 300 patients and is being conducted at approximately 40 sites in the US. Enrollment for the Phase IIb trial was initiated

Anbesol is indicated for the treatment of mouth ulcers, teething pains and denture irritation. Ashton & Parsons is used in infants for the symptomatic relief of pain and

Genzyme anticipates a shortage in the US beginning in mid-April and extending through mid-June. According to the European Medicines Agency Genzyme will only be able to reach around

Earlier in 2008, J&JPRD has got license to Isogenica’s CIS display technology, as successor in business to Centocor Research & Development, for application with the J&JPRD’s Centyrin scaffold